Main and sub-themes | Description | |
---|---|---|
1 | Cost beyond the purchase price | Costs extend from the point of purchase through the lifespan of rehabilitation technology, are not only financial in nature, and are incurred across multiple stakeholder groups |
Purchase and operational costs | Financial costs incurred in the initial purchase and then eventual replacement of technology as well as ongoing costs associated with technology operation, such as the purchase of accessories and consumables and maintenance fees | |
Infrastructure requirements | Infrastructure requirements for the environment where technology will be kept and used, for example, physical space, noise levels, and internet connection | |
Labour and time | Human labour and time necessary for technology set-up and use, including the number of people and the level of supervision required, and the ongoing commitment required from users to achieve desired outcomes | |
Risk of harm to users | Potential harm to individuals resulting from technology use, for example, the risks to physical and psychological safety and the misuse of personal data | |
2 | Benefits to ‘all’ stakeholders | Desirable outcomes of rehabilitation technology are biopsychosocial in nature, contribute to the quality of life of individual users, and represent savings to the healthcare system |
Physical function and health | Improvements in the physical function and health of technology users, that aid in the pursuit of their rehabilitation goals and reduce their incidence of re-hospitalisation | |
Psychosocial wellbeing | Improvements in the psychosocial wellbeing of technology users, including feelings of empowerment and social connection resulting from and contributing to technology use | |
Savings to the healthcare system | Savings to the healthcare system resulting from technology use, for example, due to reduced incidence of re-hospitalisation and increased efficiencies in service provision | |
3 | Trust to be earned in technology | Trust is not given easily and instead must be earned before stakeholders are willing to try, purchase, or recommend new technology |
Supporting empirical evidence | Empirical evidence that demonstrates the benefits and safety of technology use from clinical trials with representative and diverse samples of potential users | |
Transparency with stakeholders | Transparency with regards to possible benefits and risks of technology use, facilitated by the use of plain language for effective communication to potential users | |
Trial availability before purchase | Ability to trial technology personally before purchase, commitment to ongoing use, or recommendation to others | |
Recommendation by stakeholders | Recommendation or endorsement of trusted stakeholders, particularly peers who are experienced in technology operation | |
4 | Is it usable? | Rehabilitation technology that is easy to set up, use, and troubleshoot for those stakeholders who use technology |
Intuitive operation | Technology that can be used intuitively with minimal effort; ideally “plug and play” technology | |
Reliable operation | Technology that does not break down and can be used reliably by different users | |
Customisability for individual users | Technology that is customisable to individual users without the need for unanticipated purchases or adaptions | |
Instructional resources and technical support | Easy to understand, multi-format (e.g., audio-visual) instructional resources and readily accessible technical support | |
5 | Ability to access technology | Access to rehabilitation technology is influenced by its commercial availability, financial accessibility, and environment of use |
Commercial availability | Technology that is available in commercial markets, particularly those that are local to payers | |
Financial access | Technology that can be afforded by payers and that meets individual requirements for funding, for example, that has sufficient supporting empirical evidence | |
Environment of technology use | Technology that is usable in a variety of environments to meet users’ individual needs and access preferences, including in hospitals, community settings, and users’ homes | |
6 | The ‘co’ in co-design | Rehabilitation technology that has been designed with stakeholders who will both use it and influence its use |
Direct stakeholder engagement | Direct engagement of a diverse range of stakeholders, including people with disabilities, clinicians, technical experts, business stakeholders, funding bodies, and regulators | |
Understanding of diverse needs and utilisation of expertise | Understanding of the diverse needs of stakeholders and utilisation of their expertise in the development of technology |